Public Profile

Nevro Corp.

Nevro Corp., a leading medical device company headquartered in the United States, specialises in innovative solutions for chronic pain management. Founded in 2006, Nevro has made significant strides in the neuromodulation industry, particularly with its proprietary HF10 therapy, which offers a unique approach to spinal cord stimulation. With a strong presence in North America and expanding operations in Europe and Asia, Nevro is committed to improving patient outcomes through advanced technology. The company has garnered recognition for its clinical efficacy and safety, positioning itself as a frontrunner in the market. Nevro's dedication to research and development continues to drive its success, making it a pivotal player in the evolving landscape of pain management solutions.

DitchCarbon Score

How does Nevro Corp.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

18

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

4

Industry Benchmark

Nevro Corp.'s score of 18 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.

66%

Nevro Corp.'s reported carbon emissions

Nevro Corp., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor does it specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is unclear how the company is addressing its carbon footprint or contributing to climate action. In the absence of detailed information, it is essential to monitor Nevro Corp.'s future disclosures regarding their climate commitments and any potential strategies they may adopt to mitigate their environmental impact.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Nevro Corp.'s primary industry is Medical, precision and optical instruments, watches and clocks (33), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Nevro Corp. is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Nevro Corp. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

Haemonetics

US
Health and social work services (85)
Updated 2 days ago

Integra lifesciences

US
Health and social work services (85)
Updated 2 days ago

Saluda Medical Pty Ltd.

AU
Research and development services (73)
Updated 2 days ago

Medtronic, Inc.

US
Health and social work services (85)
Updated 5 days ago
DitchCarbon Score

Boston Scientific

US
Medical, precision and optical instruments, watches and clocks (33)
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers